ChemoMetec Future Growth
Future criteria checks 3/6
ChemoMetec is forecast to grow earnings and revenue by 17.2% and 14.3% per annum respectively. EPS is expected to grow by 17.1% per annum. Return on equity is forecast to be 26.8% in 3 years.
Key information
17.2%
Earnings growth rate
17.1%
EPS growth rate
Life Sciences earnings growth | 26.4% |
Revenue growth rate | 14.3% |
Future return on equity | 26.8% |
Analyst coverage | Low |
Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 629 | 234 | 185 | 249 | 3 |
6/30/2026 | 547 | 202 | 164 | 219 | 3 |
6/30/2025 | 475 | 175 | 158 | 205 | 3 |
6/30/2024 | 408 | 136 | 85 | 129 | N/A |
3/31/2024 | 405 | 140 | 98 | 138 | N/A |
12/31/2023 | 402 | 144 | 111 | 147 | N/A |
9/30/2023 | 423 | 161 | 112 | 150 | N/A |
6/30/2023 | 444 | 179 | 113 | 154 | N/A |
3/31/2023 | 453 | 179 | 117 | 156 | N/A |
12/31/2022 | 461 | 180 | 120 | 158 | N/A |
9/30/2022 | 445 | 170 | 120 | 167 | N/A |
6/30/2022 | 428 | 159 | 121 | 177 | N/A |
3/31/2022 | 393 | 145 | 94 | 148 | N/A |
12/31/2021 | 358 | 131 | 67 | 119 | N/A |
9/30/2021 | 320 | 110 | 75 | 114 | N/A |
6/30/2021 | 281 | 88 | 83 | 108 | N/A |
3/31/2021 | 262 | 81 | 79 | 105 | N/A |
12/31/2020 | 243 | 74 | 75 | 103 | N/A |
9/30/2020 | 229 | 67 | 60 | 87 | N/A |
6/30/2020 | 214 | 59 | 45 | 72 | N/A |
3/31/2020 | 206 | 54 | 39 | 66 | N/A |
12/31/2019 | 197 | 48 | 32 | 61 | N/A |
9/30/2019 | 186 | 45 | 32 | 60 | N/A |
6/30/2019 | 176 | 42 | 31 | 58 | N/A |
3/31/2019 | 158 | 37 | 26 | 50 | N/A |
12/31/2018 | 141 | 33 | 21 | 42 | N/A |
9/30/2018 | 127 | 25 | 15 | 34 | N/A |
6/30/2018 | 113 | 18 | 9 | 25 | N/A |
3/31/2018 | 107 | 15 | N/A | 20 | N/A |
12/31/2017 | 102 | 13 | N/A | 14 | N/A |
9/30/2017 | 96 | 10 | N/A | 12 | N/A |
6/30/2017 | 90 | 7 | N/A | 10 | N/A |
3/31/2017 | 88 | 6 | N/A | 13 | N/A |
12/31/2016 | 85 | 5 | N/A | 16 | N/A |
9/30/2016 | 85 | 8 | N/A | 17 | N/A |
6/30/2016 | 85 | 10 | N/A | 17 | N/A |
3/31/2016 | 80 | 11 | N/A | 16 | N/A |
12/31/2015 | 75 | 12 | N/A | 14 | N/A |
9/30/2015 | 68 | 10 | N/A | 14 | N/A |
6/30/2015 | 61 | 8 | N/A | 13 | N/A |
3/31/2015 | 56 | 5 | N/A | 9 | N/A |
12/31/2014 | 51 | 3 | N/A | 5 | N/A |
9/30/2014 | 48 | 2 | N/A | 5 | N/A |
6/30/2014 | 45 | 1 | N/A | 6 | N/A |
3/31/2014 | 44 | 1 | N/A | 6 | N/A |
12/31/2013 | 43 | 1 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CHY's forecast earnings growth (17.2% per year) is above the savings rate (1%).
Earnings vs Market: CHY's earnings (17.2% per year) are forecast to grow slower than the German market (20.8% per year).
High Growth Earnings: CHY's earnings are forecast to grow, but not significantly.
Revenue vs Market: CHY's revenue (14.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: CHY's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CHY's Return on Equity is forecast to be high in 3 years time (26.8%)